Prosecution Insights
Last updated: November 04, 2026

Biogen Extracts Private Limited

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Biogen Extracts Private Limited has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This workload is concentrated under 1 distinct examiner and 1 distinct art unit, indicating that the company's current prosecution efforts are highly localized. For a practitioner, this means there is no administrative complexity from multiple examiners or different art unit standards. The prosecution strategy can be entirely focused on the specific practices of the 1 distinct art unit.

The busiest examiner for this portfolio is MCMILLIAN, KARA RENITA, who is responsible for 1 busiest examiner pending action. Since the total pending office actions count is 1, MCMILLIAN, KARA RENITA is the sole examiner currently handling the company's active prosecution. This allows the practitioner to focus all their efforts on a single interaction at the USPTO. The outcome of the pending matter will be determined by the specific examination approach of MCMILLIAN, KARA RENITA within the 1 distinct art unit. This concentration allows for a more direct and efficient prosecution process.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MCMILLIAN, KARA RENITA 1 30.9% +37.9%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17603348 DIETARY SUPPLEMENT COMPRISING LUTEIN FOR TELOMERE PROTECTION, AND METHOD FOR PRODUCTION THEREOF MCMILLIAN, KARA RENITA —

Top Art Units

Art UnitApps
1623 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17603348 DIETARY SUPPLEMENT COMPRISING LUTEIN FOR TELOMERE PROTECTION, AND METHOD FOR PRODUCTION THEREOF MCMILLIAN, KARA RENITA 1623 §103 Non-Final OA — Pending Oct 13, 2021

Managing Biogen Extracts Private Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Biogen Extracts Private Limited have?

Biogen Extracts Private Limited has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Biogen Extracts Private Limited applications?

Kara Renita Mcmillian has the most, with 1 of Biogen Extracts Private Limited's pending office actions.

What technology area are Biogen Extracts Private Limited's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month